AZN vs SLB · P/E 28, $288.38B cap vs P/E 12, rev $8.97B
AstraZeneca PLC (AZN) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported SLB revenue for 2026-06-30 was $8.97B. Net income was $786.0M. Revenue was up 2.9% from 2026-03-31 to 2026-06-30. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the AZN and SLB stock pages for the full models.
Not investment advice.